Home > Newsletters > Drug Industry Daily > Real-Time Release Testing, Process Validation Tackled in EU Guidelines
Drug Industry Daily
April 16, 2012 | Vol. 11 No. 75
Real-Time Release Testing, Process Validation Tackled in EU Guidelines
Drugmakers may now use real-time release testing (RTRT) instead of end-product testing to demonstrate product quality for additional assessments and are no longer limited to using it for sterility testing, according to a final European Medicines Agency (EMA) guideline.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.